Ulcerative colitis trials in Belgium

In Belgium 33 Also abroad 381

33 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 11 November 2026. Ask the study team whether a trial fits you.

Phase 2Taking people
An Adaptive, Dose-Ranging, Phase 2 Study of Eltrekibart Given Alone or in Combination with Mirikizumab for the Treatment of Adult Patients with Moderately to Severely Active Ulcerative Colitis
Where
La Louviere, Yvoir
Age
18 years and over
People
587 worldwide
Run by
Eli Lilly & Co.
See details and how to join2023-507853-13-00 · EU 2023-507853-13-00
Phase 2Enrolling by invitation
Long-term Safety and Efficacy of Multiple Long-acting Antibodies Alone and in Combinations for IBD
Where
Brugge, Gent, Leuven, Roeselare, Sint-Niklaas
Age
18 years and over
People
645 worldwide
Run by
Spyre Therapeutics, Inc.
See details and how to joinNCT07652294 · EU 2025-524640-35-00
Phase 3Taking people
Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
Where
Aalst, Brussels, Kortrijk, Leuven, Liège
Age
18 years to 70 years
People
350 worldwide
Run by
Eli Lilly and Company
See details and how to joinNCT06937086 · EU 2024-520209-38-00
Phase 2Taking people
A Master Protocol (IIBD): A Study of Multiple Drugs in Adults With Ulcerative Colitis or Crohn's Disease
Where
Gent, Leuven, Roeselare
Age
18 years to 80 years
People
60 worldwide
Run by
Eli Lilly and Company
See details and how to joinNCT07483073 · EU 2025-524112-11-00
Phase 3Taking people
A Long-term Extension (LTE) Study of Guselkumab in Pediatric Participants
Where
Gent, Jette, Leuven
Age
3 years to 64 years
People
196 worldwide
Run by
Janssen Research & Development, LLC
See details and how to joinNCT06663332 · EU 2023-509560-16-00
Phase 3Taking people
A Study of JNJ-78934804 in Participants With Moderately to Severely Active Ulcerative Colitis
Where
Anderlecht, Bonheiden, Brugge, Gent, Jette, Leuven, Liège, Sint-Lambrechts-Woluwe
Age
18 years and over
People
644 worldwide
Run by
Janssen Research & Development, LLC
See details and how to joinNCT07577856 · EU 2026-525923-26-00
Phase 2Taking people
A Study to Evaluate Etrasimod Treatment in Adolescents With Ulcerative Colitis
Where
Leuven
Age
12 years to 17 years
People
36 worldwide
Run by
Pfizer
See details and how to joinNCT05287126 · EU 2022-500345-25-00
Phase 2Taking people
A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis
Where
Brugge, Gent, Leuven, Roeselare, Sint-Niklaas
Age
18 years to 75 years
People
645 worldwide
Run by
Spyre Therapeutics, Inc.
See details and how to joinNCT07012395 · EU 2025-521242-26-00
Phase 3Taking people
A Study to Learn More About How Risankizumab Works in Young Participants With Ulcerative Colitis
Where
Brussels, Liège, Sint-Lambrechts-Woluwe
Age
2 years to 17 years
People
120 worldwide
Run by
AbbVie
See details and how to joinNCT07071519 · EU 2024-514695-41-00
Phase 3Taking people
A study evaluating the effects of filgotinib in children and teenagers with ulcerative colitis
Where
Brussels, Liège, Namur
Age
Up to 17 years
People
68 worldwide
Run by
Alfasigma S.p.A.
See details and how to join2024-511458-32-00 · EU 2024-511458-32-00
No phaseTaking people
Visceral Sensitivity in IBD (Irritable Bowel Disease) and IBS (Irritable Bowel Syndrome)
Where
Leuven
Age
18 years to 65 years
People
99,999,999
Run by
KU Leuven
See details and how to joinNCT02421705
Phase 2/3Taking people
A Study Investigating Oral Ozanimod (RPC1063) in Pediatric Participants With Moderate to Severe Active Ulcerative Colitis
Where
Brussels, Edegem, Leuven, Liège
Age
2 years to 17 years
People
120 worldwide
Run by
Bristol-Myers Squibb
See details and how to joinNCT05076175
Phase 3Taking people
A Study Evaluating the Effects of Filgotinib in Children and Teenagers With Ulcerative Colitis
Where
Brussels, Liège, Namur
Age
8 years to 18 years
People
80 worldwide
Run by
Alfasigma S.p.A.
See details and how to joinNCT06865417
Phase 3Taking people
A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
Where
Yvoir
Age
16 years to 80 years
People
751 worldwide
Run by
Sanofi
See details and how to joinNCT07185009
Phase 1Taking people
An Early-Stage Study in Multiple Clinics of How Afimkibart May Affect the Body's Processing of Medicines That Rely on Cytochrome P450 Enzymes in Participants With Ulcerative Colitis
Where
Leuven, Roeselare
Age
18 years to 60 years
People
25 worldwide
Run by
Hoffmann-La Roche
See details and how to joinNCT07665723 · EU 2025-524060-38-00
Phase 3Taking people
A Long-Term Extension Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis (UC) or Crohn's Disease (CD)
Where
Liège, Sint-Lambrechts-Woluwe
Age
2 years to 17 years
People
70 worldwide
Run by
Takeda
See details and how to joinNCT06405087 · EU 2023-508804-39-00
Phase 3Taking people
A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON)
Where
Brussels, Edegem, Ghent, Leuven
Age
2 years to 19 years
People
150 worldwide
Run by
Eli Lilly and Company
See details and how to joinNCT04844606
No phaseTaking people
Study to Assess Treatment Patterns and Outcomes With Upadacitinib in Adult Participants With Inflammatory Bowel Disease in Belgium
Where
Anderlecht, Bonheiden, Genk, Ghent, Kortrijk, Liège, Lodelinsart, Roeselare, Sint-Niklaas, Tournai
Age
18 years and over
People
280
Run by
AbbVie
See details and how to joinNCT06581042
Phase 2Taking people
A Study to Test Whether BI 3032950 Helps People With Ulcerative Colitis
Where
Leuven, Liège
Age
18 years to 80 years
People
80 worldwide
Run by
Boehringer Ingelheim
See details and how to joinNCT06636656 · EU 2023-509544-10-00
Phase 4Taking people
Model-informed precision dosing during infliximab rescue therapy for patients with steroid-refractory acute severe ulcerative colitis: an exploratory study (the IGNITE study)
Where
Leuven
Age
18 years and over
People
13
Run by
UZ Leuven
See details and how to join2023-503509-12-00 · EU 2023-503509-12-00
Phase 3Taking people
A Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis or Crohn's Disease
Where
Liège, Sint-Lambrechts-Woluwe
Age
2 years to 17 years
People
70 worldwide
Run by
Takeda
See details and how to joinNCT06100289 · EU 2023-503188-40-00
Phase 2Taking people
A Phase 2a Study of the Safety and Efficacy of OD-07656 and of Subsequent Vedolizumab Therapy in Moderately to Severely Active Ulcerative Colitis
Where
Leuven
Age
18 years and over
People
70 worldwide
Run by
Odyssey Therapeutics Inc.
See details and how to join2024-520201-39-00 · EU 2024-520201-39-00
Phase 2/3Taking people
A phase 2/3, multicenter, randomized, double-blind study to evaluate the efficacy, safety, pharmacokinetics and pharmacodynamics of oral ozanimod (RPC1063) in pediatric subjects with moderately to severely active ulcerative colitis with an inadequate response to conventional therapy.
Where
Edegem, Jette, Leuven, Liège
Age
Up to 17 years
People
62 worldwide
Run by
Bristol-Myers Squibb Services Unlimited Company
See details and how to join2023-509248-86-00 · EU 2023-509248-86-00
Phase 2Taking people
A Phase 2 Platform Study to Evaluate Therapies for Inflammatory Bowel Disease
Where
Bonheiden, Edegem, Leuven
Age
18 years and over
People
54 worldwide
Run by
Mirador Therapeutics Inc.
See details and how to join2025-522001-38-00 · EU 2025-522001-38-00
No phaseTaking people
Leucine-rich α2-glycoprotein Correlation With Clinical, Endoscopic and Histological Disease Activity of IBD in a EuRopean Context
Where
Bonheiden
Age
16 years and over
People
100
Run by
Imelda GI Clinical Research Center
See details and how to joinNCT07621783